Why the study?
Does inhaled nitric oxide improve survival in patients with massive pulmonary embolism and acute right ventricular failure?
Does inhaled nitric oxide improve survival in patients with massive pulmonary embolism and acute right ventricular failure?
Inhaled nitric oxide may serve as an effective temporizing salvage therapy to decrease right ventricular afterload and support survival in massive pulmonary embolism.
Answers are grounded in this paper and cite their sources.
May support inhaled nitric oxide as temporizing therapy in massive PE; hypothesis-generating and requires prospective trials before practice change.
Inhaled nitric oxide (INO) has been shown to preferentially lower resistance in the pulmonary vasculature. The relative selectiveness of INO in accomplishing this effect makes it an attractive drug to administer as salvage therapy in patients with acute right ventricular failure secondary to pulmonary embolism. We describe 4 cases in which INO was used as a temporizing agent to decrease right ventricular after-load following massive near-fatal pulmonary embolism. All 4 patients survived to hospital discharge.
No takes yet. Share an insight, caveat, or question.
Summerfield et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: